Keywords: phase, ii, results, zeneca, seroquel, pharmaceuticals, uk

PHASE II RESULTS WITH ZENECA'S SEROQUEL

Article | 04 July 1994

Print This

Zeneca Pharmaceuticals of the UK has released data from three Phase II clinical studies of its new atypical antipsychotic agent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in